276 related articles for article (PubMed ID: 35777502)
1. Understanding the epigenetic mechanisms in SARS CoV-2 infection and potential therapeutic approaches.
Bhat S; Rishi P; Chadha VD
Virus Res; 2022 Sep; 318():198853. PubMed ID: 35777502
[TBL] [Abstract][Full Text] [Related]
2. Involvement of epigenetics in affecting host immunity during SARS-CoV-2 infection.
Behura A; Naik L; Patel S; Das M; Kumar A; Mishra A; Nayak DK; Manna D; Mishra A; Dhiman R
Biochim Biophys Acta Mol Basis Dis; 2023 Mar; 1869(3):166634. PubMed ID: 36577469
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic susceptibility to severe respiratory viral infections and its therapeutic implications: a narrative review.
Crimi E; Benincasa G; Figueroa-Marrero N; Galdiero M; Napoli C
Br J Anaesth; 2020 Dec; 125(6):1002-1017. PubMed ID: 32828489
[TBL] [Abstract][Full Text] [Related]
4. Modulation of host epigenome by coronavirus infections and developing treatment modalities for COVID-19 beyond genetics.
Rabaan AA; Al Mutair A; Alhumaid S; Al Alawi Z; Al Mohaini M; Alsalman AJ; Fawzy M; Al-Tawfiq JA; Almahmoud S; Alfouzan W; Bilal M; Dhawan M; Mohapatra RK; Tiwari R; Khan Z; Mitra S; Emran TB; Dhama K
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(19):5947-5964. PubMed ID: 34661254
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Lens to Visualize the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection in COVID-19 Pandemic.
Saksena N; Bonam SR; Miranda-Saksena M
Front Genet; 2021; 12():581726. PubMed ID: 33828579
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19.
Corley MJ; Pang APS; Dody K; Mudd PA; Patterson BK; Seethamraju H; Bram Y; Peluso MJ; Torres L; Iyer NS; Premeaux TA; Yeung ST; Chandar V; Borczuk A; Schwartz RE; Henrich TJ; Deeks SG; Sacha JB; Ndhlovu LC
J Leukoc Biol; 2021 Jul; 110(1):21-26. PubMed ID: 33464637
[TBL] [Abstract][Full Text] [Related]
7. When RING finger family proteins meet SARS-CoV-2.
Cai C; Tang YD; Zheng C
J Med Virol; 2022 Jul; 94(7):2977-2985. PubMed ID: 35257387
[TBL] [Abstract][Full Text] [Related]
8. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
Patil AM; Göthert JR; Khairnar V
Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
[TBL] [Abstract][Full Text] [Related]
9. The role of post-transcriptional regulation in SARS-CoV-2 infection and pathogenicity.
Wang X; Chang Z; Zhao T; Zhong W; Shi J; Wang G; Xu X
Front Immunol; 2023; 14():1256574. PubMed ID: 38035086
[TBL] [Abstract][Full Text] [Related]
10. An overview of potential therapeutic agents to treat COVID-19.
Dong X; Tian Z; Shen C; Zhao C
Biosci Trends; 2020 Nov; 14(5):318-327. PubMed ID: 33100290
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic mechanisms influencing COVID-19.
Sen R; Garbati M; Bryant K; Lu Y
Genome; 2021 Apr; 64(4):372-385. PubMed ID: 33395363
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: an updated review.
Dey A; Vaishak K; Deka D; Radhakrishnan AK; Paul S; Shanmugam P; Daniel AP; Pathak S; Duttaroy AK; Banerjee A
Infection; 2023 Dec; 51(6):1603-1618. PubMed ID: 36906872
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks.
Kgatle MM; Lawal IO; Mashabela G; Boshomane TMG; Koatale PC; Mahasha PW; Ndlovu H; Vorster M; Rodrigues HG; Zeevaart JR; Gordon S; Moura-Alves P; Sathekge MM
Front Immunol; 2021; 12():752380. PubMed ID: 34691068
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 disrupts host epigenetic regulation via histone mimicry.
Kee J; Thudium S; Renner DM; Glastad K; Palozola K; Zhang Z; Li Y; Lan Y; Cesare J; Poleshko A; Kiseleva AA; Truitt R; Cardenas-Diaz FL; Zhang X; Xie X; Kotton DN; Alysandratos KD; Epstein JA; Shi PY; Yang W; Morrisey E; Garcia BA; Berger SL; Weiss SR; Korb E
Nature; 2022 Oct; 610(7931):381-388. PubMed ID: 36198800
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome.
Borges RC; Hohmann MS; Borghi SM
Int Rev Immunol; 2021; 40(1-2):108-125. PubMed ID: 33191813
[TBL] [Abstract][Full Text] [Related]
16. Can Epigenetics Help Solve the Puzzle Between Concomitant Cardiovascular Injury and Severity of Coronavirus Disease 2019?
Braga CL; Acquarone M; Arona VDC; Osório BS; Barreto TG; Kian RM; Pereira JPAL; Silva MMCD; Silva BA; de Oliveira GMM; Macedo Rocco PR; Silva PL; Alencar AKN
J Cardiovasc Pharmacol; 2022 Apr; 79(4):431-443. PubMed ID: 34935698
[TBL] [Abstract][Full Text] [Related]
17. A glance upon Epigenetic and COVID-19.
Freitas NL; Azevedo PRG; BrandÃo F
An Acad Bras Cienc; 2020; 92(4):e20201451. PubMed ID: 33295584
[TBL] [Abstract][Full Text] [Related]
18. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
Abdurrahman L; Fang X; Zhang Y
Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
[TBL] [Abstract][Full Text] [Related]
19. Genetic and Epigenetic Diversity of Protein Molecules Related to SARSCoV- 2 Entry: Where We Are and Where We Should Go?
Zhu S; Chen F; Li X; Zhang Y; Wang X; Luan C
Curr Protein Pept Sci; 2022; 23(2):70-76. PubMed ID: 35105286
[TBL] [Abstract][Full Text] [Related]
20. Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.
Rohilla S
Drug Dev Res; 2021 Feb; 82(1):12-26. PubMed ID: 33216381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
